Is management of MDR-/XDR-TB in Europe adequate? A TBNET survey

A. Facchini, L. D‘Ambrosio, G. Sotgiu, G. Guenther, J. P. Zellweger, G. Bothamley, R. Centis, R. Muetterlein, S. De Lorenzo, M. Villar, K. Kliiman, V. Spinu, C. Lange, D. Manissero, G. B. Migliori, TBNET Tuberculosis Network European Trialsgroup (Tradate, Sassari, Sondalo, Italy; , Germany; Berne, Switzerland; London, United Kingdom; Lisbon, Portugal; Tartu, Estonia; Bucharest, Romania; Stockholm, Sweden)

Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis
Session: Multidrug-resistant and extensively drug-resistant tuberculosis
Session type: Oral Presentation
Number: 349
Disease area: Respiratory infections

Congress or journal article abstractSlide presentationE-poster

Abstract

MDR-TB is present in all EU countries, posing serious challenges for public health/clinical management.
The survey describes the preliminary findings in 3 EU countries, representing different TB/MDR-TB prevalence settings: low TB/low MDR-TB high TB/intermediate MDR-TB. A standardized e-tool was developed to analyze the potential critical gaps in case management that could pose a threat in fuelling further emergence of drug resistance. The tool allowed comparison of data describing management practices with international standards of TB care.
After training, 3 expert teams evaluated the original clinical records of 120 (40 per country) culture-confirmed cases: 12 XDR-TB (10%), 73 MDR-TB (60.8%) and 35 non MDR/XDR-TB (29.2%) cases.
The majority of patients were male (87/120, 72.3%); mean (±SD) age at admission was 41 (± 16) years.
Of 120 cases analyzed, 38 were cured (31.7%), 2 completed anti-TB treatment (1.7%), 8 died (6.7%), 7 defaulted (5.8%), 1 failed (0.8%) while 64 were transferred out (53.3%) with no outcome information available at the specialised centre initiating treatment.
The TB regimen and duration were not in accordance with current recommendations in 10% (12/120), and 18.3% (22/120), respectively. The dosage of anti-TB drugs was incorrect in 12.5% (15/120) patients. Environmental infection control measures (e.g., use of surgical masks, admission in isolation and negative pressure ventilation rooms) were insufficient in (80/120, 66.7%), particularly in low TB/low MDR-TB countries.
Availability of outcomes, communication between clinical and public health services, infection control measures, and treatment management as the key areas to be improved to prevent further development of drug resistance in EU.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Facchini, L. D‘Ambrosio, G. Sotgiu, G. Guenther, J. P. Zellweger, G. Bothamley, R. Centis, R. Muetterlein, S. De Lorenzo, M. Villar, K. Kliiman, V. Spinu, C. Lange, D. Manissero, G. B. Migliori, TBNET Tuberculosis Network European Trialsgroup (Tradate, Sassari, Sondalo, Italy; , Germany; Berne, Switzerland; London, United Kingdom; Lisbon, Portugal; Tartu, Estonia; Bucharest, Romania; Stockholm, Sweden). Is management of MDR-/XDR-TB in Europe adequate? A TBNET survey. Eur Respir J 2010; 36: Suppl. 54, 349

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
From policy to practice in Europe: a TBNET survey on the delivery of LTBI screening and treatment amongst migrants
Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity
Year: 2018



Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices
Source: Eur Respir J 2016; 48: 808-817
Year: 2016



Development of a standardized tool to survey MDR-/XDR-TB case management in Europe
Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2010



Development of a standardised tool to survey MDR-/XDR-TB case management in Europe
Source: Eur Respir J 2010; 36: 208-211
Year: 2010


European COPD Audit: how care is organised across Europe, methodological lessons learned - from a single country to a European study
Source: Annual Congress 2011 - Optimising healthcare for COPD across Europe
Year: 2011


XDR-TB in South Africa: from clinical management to public-health action
Source: Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management
Year: 2011


Measuring guideline adherence for the diagnosis and management of common cold and pneumonia in rural Gambia. A case for a Clinical Decision Support System in rural sub-Sarahan Africa?
Source: International Congress 2019 – Treatment of airway diseases in primary care
Year: 2019


Perceptions and practices of primary care physicians in rural India for diagnosis and management of asthma and COPD: a questionnaire survey
Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Year: 2021


Developing a framework for palliative interventions in respiratory services in Ireland: One year into an action research project
Source: Annual Congress 2011 - The COPD patient experience: care and management
Year: 2011


MDR-TB in Eastern Europe: new public health interventions
Source: International Congress 2016 – The problem of multidrug-resistant tuberculosis
Year: 2016


Centralization of M/XDR-TB care in clinical reference centres in Portugal. Experience of a regional reference centre
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


Knowledge, attitudes and practices survey of pulmonary rehabilitation among chest physicians: a first national survey in Lebanon
Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 2
Year: 2020


Knowledge, attitude and practice survey on asthma amongst physicians of 5 countries from Asia and Middle-east-North-Africa
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019

What is the yield and benefit of medical screening and medical surveillance of endangered workers?
Source: Annual Congress 2011 - New ERS Guidelines: Management of Work-Related Asthma
Year: 2011


Policies and practices on LTBI management: global WHO survey
Source: International Congress 2015 – Latent tuberculosis infection
Year: 2015



Do PLHIV know and adhere to Isoniazid preventive therapy in health facilities in Southeast Nigeria?
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020

Home NIV: results and lessons from a European survey
Source: Eur Respir Mon; 2008: 41: 392–399
Year: 2008

Awareness regarding revised national TB control programme (RNTCP) amongst physicians in a district of north India
Source: Annual Congress 2009 - Tuberculosis control
Year: 2009

Pediatric home ventilation database an effort to improve treatment – an Italian pilot for Europe.
Source: International Congress 2019 – Neonatal and paediatric intensive care
Year: 2019